Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis

Submitted by dave on Mon, 09/24/2018 - 2:52pm

Log in to download the full text paper.



Gut microbiota-derived metabolite trimethylamine-N-oxide (TMAO) is emerging as a new potentially important cause of increased cardiovascular risk. The purpose of this meta-analysis was to systematically estimate and quantify the association between TMAO plasma levels, mortality, and major adverse cardio and cerebrovascular events (MACCE).

Resistant starch as a prebiotic and synbiotic: state of the art

Non-infectious diseases such as coronary heart disease and certain cancers have become major causes of death and disability in affluent countries. Probiotics (principally lactic acid bacteria; LAB) may assist in lowering the risk of these diseases.

Experimental studies with probiotics have given generally inconclusive outcomes for infectious disease and for biomarkers for non-infectious disease. In part this situation may reflect their inability to colonise the adult human gut effectively.

The microbiome-gut-brain axis: from bowel to behavior

The ability of gut microbiota to communicate with the brain and thus modulate behavior is emerging as an exciting concept in health and disease.

Subscribe to FitEyes.com RSS Feed Subscribe to microbiota